Multiple committee members who drafted the Consensus Statement on Managing Atherosclerotic Cardiovascular Disease and Rheumatoid Arthritis will review the report, including Daniel H. Solomon, MD, MPH.
Scott Matson, MD, will review management of interstitial lung disease, focusing on monitoring disease progression and therapeutic options when the disease does progress, and Erin Theisen, MD, PhD, will discuss adjunctive treatments that are common for dermatologists but less common for rheumatologists.
Melanie Koenigshoff, MD, PhD, was one of a pair of speakers who explored the impact of aging on rheumatic diseases and avenues being explored to reverse its effects.
ABSTRACT: Colin Gliech, PhD
Lecturer John Varga, MD, MACR, will address why fibroblasts become chronically activated, why that state persists, and how the interactions among fibroblasts, immune cells, metabolism, and other cellular signals keep fibrosis going.
Anisha Dua, MD, MPH, and other presenters aim to bridge the gap between guideline recommendations and real-world diagnosis and treatment across giant cell arteritis, eosinophilic granulomatosis with polyangiitis, and ANCA-associated vasculitides.
Laura Passalent, BSc, PT, MHS, and other experienced clinicians will explain how such collaboration can streamline access to care, open up provider schedules, and give people living with rheumatic disease more control over their lives.